Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00128115
Status:
TERMINATED
Last Update Posted:
2016-01-20
First Post:
2005-08-05
Brief Title:
Treatment of Sarcopenia in Post-Hip Fracture Patients 0677-032
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Study Overview
Official Title:
Proprietary Information - Exploratory Non-Confirmatory Trial
Status:
TERMINATED
Status Verified Date:
2016-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to demonstrate an improvement in physical functional recovery following administration of Drug for 24 weeks in patients who have recently experienced a hip fracture This study will also evaluate the safety and tolerability of Drug
This is an early phase trial and some specific protocol information is proprietary and not publicly available at this time Full information is available to trial participants
This is an early phase trial and some specific protocol information is proprietary and not publicly available at this time Full information is available to trial participants
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2005_028 | None | None | None |